Skip to content

Low risk of relapse, but high mortality rate after chemotherapy for KS

Cotrimoxazole prophylaxis cuts risk of death for HIV-positive patients with TB in Zambia

Roche to halt HIV drug research

Kenyan woman wins landmark wrongful dismissal case

Study looks at blood clot risk for patients with HIV

Dutch study finds increased sexual risk-taking amongst gay men counteracts 'ART as prevention'

‘Therapeutic’ HIV vaccine leads to higher viral load, less time off treatment

Kivexa restored to first-line status in final British guidelines - but with cautions

Anti-HIV treatment as successful in South Africa as Switzerland - but starting treatment late is costing lives